Hip Osteoarthritis
Conditions
Keywords
hip osteoarthritis, physiotherapy, manual therapy
Brief summary
Dry needling is a new treatment technique, addressed to mechanical pain of the neuromusculoskeletal system. Recent investigations has developed new hypothesis about the etiology of the osteoarthritis and could be in relation to musculoskeletal disorders, but there is no published studies evaluating the results of this technique in hip osteoarthritis patients. The objective of this trial is to evaluate if dry needling is more effective in symptoms, function, range of motion, strength, muscular length, pain threshold and compared to sham dry needling and control. For this purpose the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of hip osteoarthritis Grade I-III by Scale of Kellgren and Lawrence. Patients included are randomized into 3 groups one receive Dry needling, other sham dry needling and the other is a control. Groups receive 3 treatment sessions. The variables are measured at the beginning and end of treatment. And also some variables are measured before and after each session. Patients who participated in sham dry needling or control group, when the intervention finish the investigators will be given the opportunity to receive the actual technique.
Interventions
OTHERDry needling
Dry needling is a skilled intervention that uses a thin filiform needle to penetrate the skin and stimulate underlying myofascial trigger points, muscular, and connective tissues for the management of neuromusculoskeletal pain and movement impairments.
OTHERSham Dry needling
Sham Dry needling use a non-penetrating acupuncture needle
Sponsors
Universidad de Zaragoza
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* Diagnosed medically with a X-Ray test * American College of Rheumatology Criteria
Exclusion criteria
* Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc. * Vascular or neurological disease. * Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs * Grade IV in Kellgren and Laurence Scale * Fear of needles
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Functional Capacity with functional tests | Baseline | The investigators measure the functional capacity with functional test: test Up and Go (TUG), 20 and 40 meters self-placed and 30 seconds-chair stand at baseline |
| Intensity symptoms | Baseline | The investigators measure the intensity of with a visual analogic scale pre-intervention at baseline |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Muscular length | Baseline | The investigators measure the muscular length with Passive Knee Extension test, ELY test, and modified Ober test at baseline |
| Pain threshold | Baseline | The investigators measure the pain threshold with a digital algometer in myofascial trigger points of the hip muscles, and also other bone areas to discriminate a central sensitization at baseline |
| Hip Range of motion | Baseline | The investigators measure the hip range of motion with an inclinometer at baseline |
| Functional capacity with a validated questionnaire (WOMAC) | Baseline | The investigator measure the functional capacity with WOMAC questionnaire at baseline |
| Gait in treadmill | Baseline | The investigator measure gait pattern in treadmill using wearable inertial sensors to track body kinematics during gait |
| Anxiety and depression with a validated questionnaire (HADS) | Baseline | The investigators measure the anxiety and depression with HADS questionnaire at baseline |
| Muscular strength | Baseline | The investigators measure the hip strength with a hand held dynamometer (Lafayette) at baseline |
Countries
Spain
Outcome results
None listed